BioCentury
ARTICLE | Distillery Therapeutics

Hematology

October 4, 2018 4:15 PM UTC

Cell culture and mouse studies suggest inhibiting SH2B3 could help treat FANCD2-deficient Fanconi anemia, a disorder involving loss of hematopoietic stem and progenitor cells (HSPCs). In FANCD2-defici...